Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark
Authors: Nguyen Vi , Gao Chao , Hochman Marcelo L , Kravitz Jacob , Chen Elliott H , Friedman Harold I , Wenceslau Camilla F , Chen Dongbao , Wang Yunguan , Nelson J Stuart , Jegga Anil G. , Tan Wenbin 
Published: July 2023

Abstract

Background

Port wine birthmark (PWB) is a congenital vascular malformation resulting from developmentally defective endothelial cells (ECs). Developing clinically relevant disease models for PWB studies is currently an unmet need.

Objective

Our study aims to generate PWB-derived induced pluripotent stem cells (iPSCs) and iPSC-derived ECs that preserve disease-related phenotypes.

Methods

PWB iPSCs were generated by reprogramming lesional dermal fibroblasts and differentiated into ECs. RNA-seq was performed to identify differentially expressed genes (DEGs) and enriched pathways. The functional phenotypes of iPSC-derived ECs were characterized by capillary-like structure (CLS) formationin vitroand Geltrex plug-in assayin vivo.

Results

Human PWB and control iPSC lines were generated through reprogramming of dermal fibroblasts by introducing the “Yamanaka factors” (Oct3/4, Sox2, Klf4, c-Myc) into them; the iPSCs were successfully differentiated into ECs. These iPSCs and their derived ECs were validated by expression of a series of stem cell and EC biomarkers, respectively. PWB iPSC-derived ECs showed impaired CLSin vitrowith larger perimeters and thicker branches as compared to control iPSC-derived ECs. In the plug-in assay, perfused human vasculature formed by PWB iPSC- derived ECs showed bigger perimeters and greater densities than those formed by control iPSC- derived ECs in severe combined immune deficient (SCID) mice. The transcriptome analysis showed that dysregulated pathways of stem cell differentiation, Hippo, Wnt, and focal adhesion persisted through differentiation of PWB iPSCs to ECs. Functional enrichment analysis showed that Hippo and Wnt pathway-related PWB DEGs are enriched for vasculature development, tube morphology, endothelium development, and EC differentiation. Further, members of the zinc finger (ZNF) gene family were overrepresented among the DEGs in PWB iPSCs. ZNF DEGs confer significant functions in transcriptional regulation, chromatin remodeling, protein ubiquitination, and retinoic acid receptor signaling. Furthermore, NF-kappa B, TNF, MAPK, and cholesterol metabolism pathways were dysregulated in PWB ECs as readouts of impaired differentiation.

Conclusions

PWB iPSC-derived ECs render a novel and clinically-relevant disease model by retaining pathological phenotypes. Our data demonstrate multiple pathways, such as Hippo and Wnt, NF-kappa B, TNF, MAPK, and cholesterol metabolism, are dysregulated, which may contribute to the development of differentiation-defective ECs in PWB.

Bulleted statements

What is already known about this topic?

Port Wine Birthmark (PWB) is a congenital vascular malformation with an incidence rate of 0.1 – 0.3 % per live births.

PWB results from developmental defects in the dermal vasculature; PWB endothelial cells (ECs) have differentiational impairments.

Pulse dye laser (PDL) is currently the preferred treatment for PWB; unfortunately, the efficacy of PDL treatment of PWB has not improved over the past three decades.

What does this study add?

Induced pluripotent stem cells (iPSCs) were generated from PWB skin fibroblasts and differentiated into ECs.

PWB ECs recapitulated their pathological phenotypes such as forming enlarged blood vessels in vitro and in vivo.

Hippo and Wnt pathways were dysregulated in PWB iPSCs and ECs.

Zinc-finger family genes were overrepresented among the differentially expressed genes in PWB iPSCs.

Dysregulated NF-kappa B, TNF, MAPK, and cholesterol metabolism pathways were enriched in PWB ECs.

What is the translational message?

Targeting Hippo and Wnt pathways and Zinc-finger family genes could restore the physiological differentiation of ECs.

Targeting NF-kappa B, TNF, MAPK, and cholesterol metabolism pathways could mitigate the pathological progression of PWB.

These mechanisms may lead to the development of paradigm-shifting therapeutic interventions for PWB.